BIOMAT Database Logo BIOMAT Database Logo

Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma. 2004

Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
Department of Medicine III (Hematology, Oncology and Transfusionmedicine), Charité, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. alexander.schmittel@charite.de

Adjuvant treatment strategies in uveal melanoma require determination of prognostic factors. Patients, who received primary therapy in 1994 and 1995 at our institution, were analysed. Of 271 patients 85% and 71% were available for follow up of 4 and 5 years. Forty three patients (15.9%) developed metastases. Kaplan-Meier analysis revealed a 5-year progression free survival (PFS) of 79% for the whole patient cohort. Extraocular tumor growth (EOG), ciliary body involvement or a largest tumor diameter (LTD) >14 mm were associated with a significantly lower 5-year PFS of 28%, 61.4% or 67.6%. In multivariate analysis time to progression was significantly associated with ciliary body involvement and LTD, and survival was associated with ciliary body involvement. Ciliary body involvement profoundly increased the risk for metastases (hazard ratio 6.9, P<0.001) within the first 3 years. This study determined patients with ciliary body involvement to be candidates for future adjuvant therapeutic interventions.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004812 Epidemiologic Methods Research techniques that focus on study designs and data gathering methods in human and animal populations. Epidemiologic Method,Epidemiological Methods,Methods, Epidemiologic,Epidemiological Method,Method, Epidemiologic,Method, Epidemiological,Methods, Epidemiological
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
Prognostic factors in 1,521 melanoma patients with distant metastases.
September 1995, Journal of the American College of Surgeons,
Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
Malignant melanoma prognostic factors 6: distant metastases and length of survival.
September 1984, The Journal of dermatologic surgery and oncology,
Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
Prognostic factors for survival in melanoma patients with brain metastases.
April 2011, Cancer,
Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
Survival of patients with metastases from uveal melanoma.
March 1991, Ophthalmology,
Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
Prognostic factors of liver metastases from uveal melanoma.
October 2005, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
December 2017, Journal of neuro-oncology,
Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
[Prognostic factors for uveal melanoma].
January 2015, Vestnik oftalmologii,
Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
Survival and prognostic factors in patients with brain metastases from malignant melanoma.
April 2004, Onkologie,
Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
February 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Alexander Schmittel, and Nikolaos E Bechrakis, and Peter Martus, and Dominic Mutlu, and Carmen Scheibenbogen, and Norbert Bornfeld, and Michael H Foerster, and Eckhard Thiel, and Ulrich Keilholz
Prognostic factors in uveal melanoma.
June 2001, Melanoma research,
Copied contents to your clipboard!